We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

WEE1 Inhibitor AZD1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

This study has suspended participant recruitment.
(Other - Data reconciliation)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01849146
First Posted: May 8, 2013
Last Update Posted: December 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Study Completion Date: No date given
  Estimated Primary Completion Date: August 15, 2018 (Final data collection date for primary outcome measure)